Lamont B Koo
Examiner (ID: 8622, Phone: (571)272-0984 , Office: P/2823 )
Most Active Art Unit | 2813 |
Art Unit(s) | 2813, 2823 |
Total Applications | 538 |
Issued Applications | 377 |
Pending Applications | 55 |
Abandoned Applications | 106 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 3933753
[patent_doc_number] => 05972676
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders'
[patent_app_type] => 1
[patent_app_number] => 8/974655
[patent_app_country] => US
[patent_app_date] => 1997-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20868
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972676.pdf
[firstpage_image] =>[orig_patent_app_number] => 974655
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/974655 | Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders | Nov 18, 1997 | Issued |
08/875967 | PLANT XYLOSE ISOMERASE | Nov 5, 1997 | Abandoned |
08/959279 | METHOD OF INDUCING CELL CYCLE STASIS | Oct 23, 1997 | Abandoned |
Array
(
[id] => 4050570
[patent_doc_number] => 05932466
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Creatine amidinohydrolase gene, a novel recombinant DNA, and a process for producing creatine amidinohydrolase'
[patent_app_type] => 1
[patent_app_number] => 8/947726
[patent_app_country] => US
[patent_app_date] => 1997-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4523
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932466.pdf
[firstpage_image] =>[orig_patent_app_number] => 947726
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/947726 | Creatine amidinohydrolase gene, a novel recombinant DNA, and a process for producing creatine amidinohydrolase | Oct 8, 1997 | Issued |
Array
(
[id] => 4196779
[patent_doc_number] => 06013505
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'Topoisomerase I'
[patent_app_type] => 1
[patent_app_number] => 8/946475
[patent_app_country] => US
[patent_app_date] => 1997-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21891
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013505.pdf
[firstpage_image] =>[orig_patent_app_number] => 946475
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946475 | Topoisomerase I | Oct 6, 1997 | Issued |
Array
(
[id] => 3980847
[patent_doc_number] => 05958740
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Genetically enhanced cellulase production in Pseudomonas cellulosa using recombinant DNA technology'
[patent_app_type] => 1
[patent_app_number] => 8/934883
[patent_app_country] => US
[patent_app_date] => 1997-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4898
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958740.pdf
[firstpage_image] =>[orig_patent_app_number] => 934883
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/934883 | Genetically enhanced cellulase production in Pseudomonas cellulosa using recombinant DNA technology | Sep 21, 1997 | Issued |
Array
(
[id] => 1017826
[patent_doc_number] => 06890720
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-10
[patent_title] => 'Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis'
[patent_app_type] => utility
[patent_app_number] => 09/254032
[patent_app_country] => US
[patent_app_date] => 1997-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4677
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/890/06890720.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254032
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254032 | Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis | Aug 31, 1997 | Issued |
Array
(
[id] => 4236189
[patent_doc_number] => 06090612
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Calcineurin regulatable adenylate cyclase'
[patent_app_type] => 1
[patent_app_number] => 8/894173
[patent_app_country] => US
[patent_app_date] => 1997-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31814
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090612.pdf
[firstpage_image] =>[orig_patent_app_number] => 894173
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/894173 | Calcineurin regulatable adenylate cyclase | Aug 12, 1997 | Issued |
Array
(
[id] => 3928432
[patent_doc_number] => 05928688
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'DNA encoding phage abortive infection protein from Lactococcus lactis and method of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/909425
[patent_app_country] => US
[patent_app_date] => 1997-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9240
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928688.pdf
[firstpage_image] =>[orig_patent_app_number] => 909425
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/909425 | DNA encoding phage abortive infection protein from Lactococcus lactis and method of use thereof | Aug 10, 1997 | Issued |
Array
(
[id] => 8163348
[patent_doc_number] => 08173113
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-05-08
[patent_title] => 'Bioadhesive composition and patch'
[patent_app_type] => utility
[patent_app_number] => 08/855933
[patent_app_country] => US
[patent_app_date] => 1997-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11256
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173113.pdf
[firstpage_image] =>[orig_patent_app_number] => 08855933
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/855933 | Bioadhesive composition and patch | May 13, 1997 | Issued |
Array
(
[id] => 4138320
[patent_doc_number] => 06060297
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Rho protein'
[patent_app_type] => 1
[patent_app_number] => 8/842976
[patent_app_country] => US
[patent_app_date] => 1997-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 18255
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060297.pdf
[firstpage_image] =>[orig_patent_app_number] => 842976
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/842976 | Rho protein | Apr 16, 1997 | Issued |
Array
(
[id] => 3937081
[patent_doc_number] => 05871970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Calcium-binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/828242
[patent_app_country] => US
[patent_app_date] => 1997-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 17163
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871970.pdf
[firstpage_image] =>[orig_patent_app_number] => 828242
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/828242 | Calcium-binding protein | Mar 30, 1997 | Issued |
Array
(
[id] => 3999471
[patent_doc_number] => 05858759
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'D-N-carbamoyl-amino acid amidohydrolase and hydantoinase'
[patent_app_type] => 1
[patent_app_number] => 8/815356
[patent_app_country] => US
[patent_app_date] => 1997-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16904
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858759.pdf
[firstpage_image] =>[orig_patent_app_number] => 815356
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/815356 | D-N-carbamoyl-amino acid amidohydrolase and hydantoinase | Mar 10, 1997 | Issued |
Array
(
[id] => 4083706
[patent_doc_number] => 06025172
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Isolation and sequencing of the hazel FAD2-Ngene'
[patent_app_type] => 1
[patent_app_number] => 8/811177
[patent_app_country] => US
[patent_app_date] => 1997-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6013
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025172.pdf
[firstpage_image] =>[orig_patent_app_number] => 811177
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/811177 | Isolation and sequencing of the hazel FAD2-Ngene | Mar 3, 1997 | Issued |
Array
(
[id] => 3992313
[patent_doc_number] => 05985627
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Modified carboxypeptidase'
[patent_app_type] => 1
[patent_app_number] => 8/807263
[patent_app_country] => US
[patent_app_date] => 1997-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9486
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985627.pdf
[firstpage_image] =>[orig_patent_app_number] => 807263
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/807263 | Modified carboxypeptidase | Feb 27, 1997 | Issued |
Array
(
[id] => 4189581
[patent_doc_number] => 06043033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Human prostate-associated protease'
[patent_app_type] => 1
[patent_app_number] => 8/807151
[patent_app_country] => US
[patent_app_date] => 1997-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18961
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043033.pdf
[firstpage_image] =>[orig_patent_app_number] => 807151
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/807151 | Human prostate-associated protease | Feb 26, 1997 | Issued |
Array
(
[id] => 4176958
[patent_doc_number] => 06037164
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Human parvulin-like protein'
[patent_app_type] => 1
[patent_app_number] => 8/801743
[patent_app_country] => US
[patent_app_date] => 1997-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17938
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037164.pdf
[firstpage_image] =>[orig_patent_app_number] => 801743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/801743 | Human parvulin-like protein | Feb 13, 1997 | Issued |
Array
(
[id] => 1452514
[patent_doc_number] => 06461609
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Recombinant -galactosidase a therapy for Fabry disease'
[patent_app_type] => B1
[patent_app_number] => 08/790491
[patent_app_country] => US
[patent_app_date] => 1997-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6904
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/461/06461609.pdf
[firstpage_image] =>[orig_patent_app_number] => 08790491
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/790491 | Recombinant -galactosidase a therapy for Fabry disease | Jan 28, 1997 | Issued |
08/788975 | CYTOSOLIC PHOSPHOLIPASE A2-BETA ENZYMES | Jan 23, 1997 | Abandoned |
Array
(
[id] => 3909792
[patent_doc_number] => 06001631
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Topoisomerase IV, corresponding nucleotide sequences and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/776265
[patent_app_country] => US
[patent_app_date] => 1997-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 14434
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001631.pdf
[firstpage_image] =>[orig_patent_app_number] => 776265
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/776265 | Topoisomerase IV, corresponding nucleotide sequences and uses thereof | Jan 23, 1997 | Issued |